Tiny sensor could spot Post-Surgery dumping syndrome early

NCT ID NCT07605481

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a small, wearable continuous glucose monitor (CGM) can accurately diagnose dumping syndrome in people who have had surgery for esophageal cancer. Dumping syndrome happens when food moves too quickly into the small intestine, causing symptoms like dizziness, rapid heartbeat, and low blood sugar. Researchers will compare the CGM results to the standard oral glucose tolerance test in 30 adults to see if the sensor is a reliable and easier way to detect the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINOUS GLUCOSE MEASUREMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Samsung Medical Center

    RECRUITING

    Seoul, Gangnam-gu Irwon-Ro 81, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.